The therapeutic potential of C-C chemokine receptor antagonists in nonalcoholic steatohepatitis

• Asıl Yazarlar: Michael Doulberis (Yazar), Kasiani Papadimitriou (Yazar), Apostolis Papaefthymiou (Yazar), Jannis Kountouras (Yazar), Stergios A. Polyzos (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Open Exploration Publishing Inc., 2020-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Pooled prevalence of nonalcoholic fatty liver disease (NAFLD) globally is about 25%. Nonalcoholic steatohepatitis (NASH) with advanced fibrosis has been linked with substantial morbidity and mortality, without having to-date any licensed treatment. C-C chemokine receptor (CCR) antagonists have been...